These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 34015720)

  • 1. Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19).
    Andrew M; Jayaraman G
    Carbohydr Res; 2021 Jul; 505():108326. PubMed ID: 34015720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2.
    Song S; Peng H; Wang Q; Liu Z; Dong X; Wen C; Ai C; Zhang Y; Wang Z; Zhu B
    Food Funct; 2020 Sep; 11(9):7415-7420. PubMed ID: 32966484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolic events and Covid-19.
    Ribes A; Vardon-Bounes F; Mémier V; Poette M; Au-Duong J; Garcia C; Minville V; Sié P; Bura-Rivière A; Voisin S; Payrastre B
    Adv Biol Regul; 2020 Aug; 77():100735. PubMed ID: 32773098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
    Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses.
    Ray B; Ali I; Jana S; Mukherjee S; Pal S; Ray S; Schütz M; Marschall M
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.
    Witvrouw M; De Clercq E
    Gen Pharmacol; 1997 Oct; 29(4):497-511. PubMed ID: 9352294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2.
    Alam MA; Parra-Saldivar R; Bilal M; Afroze CA; Ahmed MN; Iqbal HMN; Xu J
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33917694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulopathy in COVID-19: Focus on vascular thrombotic events.
    Shi W; Lv J; Lin L
    J Mol Cell Cardiol; 2020 Sep; 146():32-40. PubMed ID: 32681845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications.
    Tafazoli A; Anil Kumar S; Othman M
    Platelets; 2022 Jan; 33(1):48-53. PubMed ID: 34847829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19.
    Haji Aghajani M; Moradi O; Amini H; Azhdari Tehrani H; Pourheidar E; Rabiei MM; Sistanizad M
    J Med Virol; 2021 Sep; 93(9):5390-5395. PubMed ID: 33913549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor.
    Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W
    mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of SARS-CoV-2 Virus Entry by the Crude Polysaccharides of Seaweeds and Abalone Viscera In Vitro.
    Yim SK; Kim K; Kim IH; Chun SH; Oh TH; Kim JU; Kim JW; Jung WH; Moon HS; Ku BS; Jung KJ
    Mar Drugs; 2021 Apr; 19(4):. PubMed ID: 33921174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocktail polysaccharides isolated from Ecklonia kurome against the SARS-CoV-2 infection.
    Zhang S; Pei R; Li M; Su H; Sun H; Ding Y; Su M; Huang C; Chen X; Du Z; Jin C; Zang Y; Li J; Xu Y; Chen X; Zhang B; Ding K
    Carbohydr Polym; 2022 Jan; 275():118779. PubMed ID: 34742404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing.
    Glebov OO
    FEBS J; 2020 Sep; 287(17):3664-3671. PubMed ID: 32428379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials.
    Al-Horani RA; Kar S; Aliter KF
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19.
    Mirabelli C; Wotring JW; Zhang CJ; McCarty SM; Fursmidt R; Pretto CD; Qiao Y; Zhang Y; Frum T; Kadambi NS; Amin AT; O'Meara TR; Spence JR; Huang J; Alysandratos KD; Kotton DN; Handelman SK; Wobus CE; Weatherwax KJ; Mashour GA; O'Meara MJ; Chinnaiyan AM; Sexton JZ
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34413211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step.
    Chan SW; Shafi T; Ford RC
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features and in vitro antiviral activities of sulfated polysaccharides from Sphacelaria indica.
    Bandyopadhyay SS; Navid MH; Ghosh T; Schnitzler P; Ray B
    Phytochemistry; 2011 Feb; 72(2-3):276-83. PubMed ID: 21167536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.
    Santopolo S; Riccio A; Santoro MG
    Biochem Biophys Res Commun; 2021 Jan; 538():80-87. PubMed ID: 33303190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
    Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.